{
  "actions": [
    {
      "acted_at": "2001-05-02", 
      "references": [
        {
          "reference": "CR E704", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2001-05-03", 
      "committee": "House Committee on Ways and Means", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Ways and Means.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2001-05-08", 
      "in_committee": "House Committee on Ways and Means", 
      "references": [], 
      "subcommittee": "Trade", 
      "text": "Referred to the Subcommittee on Trade.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hconres126-107", 
  "bill_type": "hconres", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM", 
      "subcommittee": "Subcommittee on Trade", 
      "subcommittee_id": "04"
    }
  ], 
  "congress": "107", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2001-05-03", 
  "number": "126", 
  "official_title": "Expressing the sense of the Congress that the United States Trade Representative should investigate whether any price control program governing the cost of medication in Mexico or Canada violates any trade agreement.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "district": "2", 
    "name": "Duncan, John J., Jr.", 
    "state": "TN", 
    "thomas_id": "00322", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2001-05-03", 
  "subjects": [
    "Canada", 
    "Commerce", 
    "Economics and public finance", 
    "Foreign trade and international finance", 
    "Governmental investigations", 
    "Health", 
    "International affairs", 
    "Latin America", 
    "Mexico", 
    "Prescription pricing", 
    "Price regulation", 
    "Trade agreements"
  ], 
  "subjects_top_term": "Foreign trade and international finance", 
  "summary": {
    "as": "Introduced", 
    "date": "2001-05-03", 
    "text": "Expresses the sense of Congress that the United States Trade Representative should investigate whether any price control program governing the cost of medication in Mexico or Canada violates any trade agreement (or otherwise denies benefits to the United States under any trade agreement), or is discriminatory and burdens or restricts U.S. commerce."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Expressing the sense of the Congress that the United States Trade Representative should investigate whether any price control program governing the cost of medication in Mexico or Canada violates any trade agreement.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:50:50-05:00"
}